5 billion in cash.

The boards of directors of both companies have accepted the proposed acquisition. Barclays Capital served as an exclusive economic advisor to Abbott upon this transaction. Abbott Conference Contact Abbott will conduct a special conference contact today at 7 a.m. Central time to supply an overview of the transaction. The live Web cast will be accessible through Abbott’s Investor Relations Web site at About Solvay Pharmaceuticals Solvay Pharmaceuticals is normally a research driven group of businesses that constitutes the global pharmaceutical business of the Solvay Group.‘This points to the possibility that dementia in atrial fibrillation individuals is partly due to little repetitive clots and/or bleeds in the mind.’ Results from the Intermountain Medical Center Heart Institute research were collected from 2,693 patients, with 4.1 % of them being diagnosed with dementia. Results were based on the %age of period their blood-thinning medications were within the range. The additional time their dosages were within the range, the less risk that they had of developing dementia.